Literature DB >> 15972953

Tenascin-C regulates recruitment of myofibroblasts during tissue repair after myocardial injury.

Masashi Tamaoki1, Kyoko Imanaka-Yoshida, Kazuto Yokoyama, Tomohiro Nishioka, Hiroyasu Inada, Michiaki Hiroe, Teruyo Sakakura, Toshimichi Yoshida.   

Abstract

Tenascin-C (TN-C) is an extracellular matrix molecule that is expressed during wound healing in various tissues. Although not detectable in the normal adult heart, it is expressed under pathological conditions. Previously, using a rat model, we found that TN-C was expressed during the acute stage after myocardial infarction and that alpha-smooth muscle actin (alpha-SMA)-positive myofibroblasts appeared in TN-C-positive areas. In the present study, we examined whether TN-C controls the dynamics of myofibroblast recruitment and wound healing after electrical injury to the myocardium of TN-C knockout (TNKO) mice compared with wild-type (WT) mice. In TNKO mice, myocardial repair seemed to proceed normally, but the appearance of myofibroblasts was delayed. With cultured cardiac fibroblasts, TN-C significantly accelerated cell migration, alpha-SMA expression, and collagen gel contraction but did not affect proliferation. Using recombinant fragments of murine TN-C, the functional domain responsible for promoting migration of cardiac fibroblasts was mapped to the conserved fibronectin type III (FNIII)-like repeats and the fibrinogen (Fbg)-like domain. Furthermore, alternatively spliced FNIII and Fbg-like domains proved responsible for the up-regulation of alpha-SMA expression. These results indicate that TN-C promotes recruitment of myofibroblasts in the early stages of myocardial repair by stimulating cell migration and differentiation.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15972953      PMCID: PMC1603439          DOI: 10.1016/S0002-9440(10)62954-9

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  57 in total

Review 1.  The infarcted myocardium: simply dead tissue, or a lively target for therapeutic interventions.

Authors:  J P Cleutjens; W M Blankesteijn; M J Daemen; J F Smits
Journal:  Cardiovasc Res       Date:  1999-11       Impact factor: 10.787

2.  Modulation of heart fibroblast migration and collagen gel contraction by IGF-I.

Authors:  S Kanekar; T K Borg; L Terracio; W Carver
Journal:  Cell Adhes Commun       Date:  2000

Review 3.  Myofibroblasts: paracrine cells important in health and disease.

Authors:  D W Powell
Journal:  Trans Am Clin Climatol Assoc       Date:  2000

4.  Involvement of tenascin-C in proliferation and migration of laryngeal carcinoma cells.

Authors:  T Yoshida; E Yoshimura; H Numata; Y Sakakura; T Sakakura
Journal:  Virchows Arch       Date:  1999-11       Impact factor: 4.064

5.  Analysis of tenascin mRNA expression in the murine mammary gland from embryogenesis to carcinogenesis: an in situ hybridization study.

Authors:  I Kalembey; T Yoshida; K Iriyama; T Sakakura
Journal:  Int J Dev Biol       Date:  1997-08       Impact factor: 2.203

Review 6.  Tenascin-C in development and disease: gene regulation and cell function.

Authors:  P L Jones; F S Jones
Journal:  Matrix Biol       Date:  2000-12       Impact factor: 11.583

7.  Alpha-smooth muscle actin expression upregulates fibroblast contractile activity.

Authors:  B Hinz; G Celetta; J J Tomasek; G Gabbiani; C Chaponnier
Journal:  Mol Biol Cell       Date:  2001-09       Impact factor: 4.138

8.  Tenascin-C modulates adhesion of cardiomyocytes to extracellular matrix during tissue remodeling after myocardial infarction.

Authors:  K Imanaka-Yoshida; M Hiroe; T Nishikawa; S Ishiyama; T Shimojo; Y Ohta; T Sakakura; T Yoshida
Journal:  Lab Invest       Date:  2001-07       Impact factor: 5.662

Review 9.  The tenascin family of ECM glycoproteins: structure, function, and regulation during embryonic development and tissue remodeling.

Authors:  F S Jones; P L Jones
Journal:  Dev Dyn       Date:  2000-06       Impact factor: 3.780

10.  Co-expression of tenascin-C and vimentin in human breast cancer cells indicates phenotypic transdifferentiation during tumour progression: correlation with histopathological parameters, hormone receptors, and oncoproteins.

Authors:  N Dandachi; C Hauser-Kronberger; E Moré; B Wiesener; G W Hacker; O Dietze; G Wirl
Journal:  J Pathol       Date:  2001-02       Impact factor: 7.996

View more
  74 in total

Review 1.  Matricellular proteins in drug delivery: Therapeutic targets, active agents, and therapeutic localization.

Authors:  Andrew J Sawyer; Themis R Kyriakides
Journal:  Adv Drug Deliv Rev       Date:  2016-01-04       Impact factor: 15.470

Review 2.  Extracellular Matrix in Ischemic Heart Disease, Part 4/4: JACC Focus Seminar.

Authors:  Nikolaos G Frangogiannis; Jason C Kovacic
Journal:  J Am Coll Cardiol       Date:  2020-05-05       Impact factor: 24.094

Review 3.  Matricellular proteins in cardiac adaptation and disease.

Authors:  Nikolaos G Frangogiannis
Journal:  Physiol Rev       Date:  2012-04       Impact factor: 37.312

Review 4.  Genetic enhancement of stem cell engraftment, survival, and efficacy.

Authors:  Marc S Penn; Abeel A Mangi
Journal:  Circ Res       Date:  2008-06-20       Impact factor: 17.367

5.  Type A dissection and chronic dilatation: tenascin-C as a key factor in destabilization of the aortic wall.

Authors:  Karola Trescher; Barbara Thometich; Svitlana Demyanets; Hermann Kassal; Roland Sedivy; Reginald Bittner; Christoph Holzinger; Bruno K Podesser
Journal:  Interact Cardiovasc Thorac Surg       Date:  2013-05-08

Review 6.  Fibrinogen-Related Proteins in Tissue Repair: How a Unique Domain with a Common Structure Controls Diverse Aspects of Wound Healing.

Authors:  Lorena Zuliani-Alvarez; Kim S Midwood
Journal:  Adv Wound Care (New Rochelle)       Date:  2015-05-01       Impact factor: 4.730

7.  Role of matricellular proteins in cardiac tissue remodeling after myocardial infarction.

Authors:  Yutaka Matsui; Junko Morimoto; Toshimitsu Uede
Journal:  World J Biol Chem       Date:  2010-05-26

Review 8.  Cardiac fibroblast: the renaissance cell.

Authors:  Colby A Souders; Stephanie L K Bowers; Troy A Baudino
Journal:  Circ Res       Date:  2009-12-04       Impact factor: 17.367

9.  Infarct-derived chondroitin sulfate proteoglycans prevent sympathetic reinnervation after cardiac ischemia-reperfusion injury.

Authors:  Ryan T Gardner; Beth A Habecker
Journal:  J Neurosci       Date:  2013-04-24       Impact factor: 6.167

10.  Absence of SPARC results in increased cardiac rupture and dysfunction after acute myocardial infarction.

Authors:  Mark W M Schellings; Davy Vanhoutte; Melissa Swinnen; Jack P Cleutjens; Jacques Debets; Rick E W van Leeuwen; Jan d'Hooge; Frans Van de Werf; Peter Carmeliet; Yigal M Pinto; E Helene Sage; Stephane Heymans
Journal:  J Exp Med       Date:  2008-12-22       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.